American Cannabis MSO Portfolio Went UP 5% Last Week; Now +16% YTD
Introduction
The munKNEE American Cannabis MSO Portfolio is UP 15.9% YTD - and UP 5.2% last week - despite the fact that all its constituents are faring poorly in 4 key financial metrics expressed as a % of net revenue.
The financial metrics used in this analysis are a company's:
- Gross Profit Margin is the profit remaining after subtracting the cost of goods sold from revenue. A high gross profit margin reflects how efficiently a company manages its operating expenses, i.e. how successfully a company is producing profit over and above its costs;
- Selling General and Administration (SG&A) Expenses are the costs a company incurs to run its business, which include salaries, marketing, rent, utilities, and office supplies and the SG&A margin is the percentage of revenue consumed by these expenses and shows how much revenue is being absorbed by overhead costs;
- Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) is the cash profit generated by a company's operations excluding non-recurring, irregular, and one-time items such as unrealized gains or losses; non-cash expenses (depreciation, amortization); litigation expenses; gains or losses on foreign exchange; goodwill impairments; non-operating income; and share-based compensation that may distort the EBITDA;
- Net Profit or Loss Margin, or simply net margin, measures how much net income or profit a company generates as a percentage of its revenue. The net profit margin illustrates how much of each dollar in revenue collected by a company translates into profit.
- Source
Below are how each constituent's stock performed last week, MTD and YTD along with their 4 financial metrics as a % of net revenue as per their most recent quarterly financial reports and its rank compared to its peers; their market capitalization and any recent news, analyses and/or commentary on the company.
The munKNEE American Cannabis MSO Portfolio
- Curaleaf (CURLF): UP 10.2% last week; UP 9.6% MTD; UP 1.7% YTD
- Market Capitalization: $3,220M
- Rank of Gross Profit Margin as a % of Net Revenue: #7 @ 45.5%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #3 @ 32.1 %
- Rank of Adjusted EBITDA as a % of Net Revenue: #6 @ 22.6 %
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #5 @ (14.3)%
- Recent News, Analyses and/or Commentary:
- Cresco Labs (CRLBF): UP 9.0% last week; UP 7.6% MTD; UP 25.9% YTD
- Market Capitalization: $782M
- Rank of Gross Profit Margin as a % of Net Revenue: #6 @ 47.1 %
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #2 @ 29.9%
- Rank of Adjusted EBITDA as a % of Net Revenue: #4 @ 28.8%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #3 @ (2.8)%
- Recent News, Analyses and/or Commentary:
- Ayr Wellness (AYRWF): UP 8.4% last week; UP 4.6% MTD; UP 14.4% YTD
- Market Capitalization: $240M
- Rank of Gross Profit Margin as a % of Net Revenue: #1 @ 53.1%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #6 @ 35.6%
- Rank of Adjusted EBITDA as a % of Net Revenue: #5 @ 24.7%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #6 @ (16.9)%
- Recent News, Analyses and/or Commentary:
- Trulieve Cannabis (TCNNF): UP 7.8% last week; UP 8.0% MTD; UP 91.6% YTD
- Market Capitalization: $1,880M
- Rank of Gross Profit Margin as a % of Net Revenue: #4 @ 49.1%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #4 @ 34.0%
- Rank of Adjusted EBITDA as a % of Net Revenue: #2 @ 35.6%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #4 @ (10.7)%
- Recent News, Analyses and/or Commentary:
- Verano (VRNOF): UP 5.1% last week; UP 1.4% MTD; DOWN 16.5% YTD
- Market Capitalization: $1,380M
- Rank of Gross Profit Margin as a % of Net Revenue: #3 @ 51.0%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #7 @ 39.0%
- Rank of Adjusted EBITDA as a % of Net Revenue: #3 @ 30.3%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #2 @ (2.2)%
- Recent News, Analyses and/or Commentary:
- TerrAscend (TSNDF): UP 1.5% last week; DOWN 0.7% MTD; DOWN 17.8% YTD
- Market Capitalization: $493M
- Rank of Gross Profit Margin as a % of Net Revenue: #5 @ 48.0%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #5 @ 34.7%
- Rank of Adjusted EBITDA as a % of Net Revenue: #7 @ 20.1%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #7 @ (18.4)%
- Recent News, Analyses and/or Commentary:
- Green Thumb (GTBIF): UP 0.9% last week; DOWN 1.8% MTD; UP 2.7% YTD
- Market Capitalization: $2,780M
- Rank of Gross Profit Margin as a % of Net Revenue: #2 @ 52.5%
- Rank of Selling, General, and Administrative Expenses as a % of Net Revenue: #1 @ 25.0%
- Rank of Adjusted EBITDA as a % of Net Revenue: #1 @ 35.7%
- Rank of Net Profit Margin (or Loss) as a % of Net Revenue: #1 @ 11.3%
- Recent News, Analyses and/or Commentary:
Summary
On average, the MSO Portfolio was UP 5.2% last week, is UP 3.4% MTD and is now UP 15.9% YTD.
The above financial metrics as a % of net revenue by company have been averaged and are listed as follows, in descending order, to provide a comparative analysis of their respective financial health:
- (1) Green Thumb; (2) Trulieve; (3) Cresco Labs; (4) Verano; (5) Ayr Wellness; (6) Curaleaf; (7) TerrAscend
The above information will be updated when the Q2 financial reports are released the week of August 12th.
More By This Author:
Canadian Cannabis LP Portfolio Popped 11% Last Week; Now +18% YTD
Micro/Small Cap AI Stocks Portfolio Jumped 13.5% Last Week
Pure-Play Quantum Computing Stocks Portfolio UP 13% Last Week
Disclosure: None
This article has been composed with the exclusive application of the human intelligence (HI) of the author. No artificial intelligence (AI) technology has been deployed. ...
more
Comments
No Thumbs up yet!
